H.ZhouW.ZhangK
Hypoglycemia: Adult patients receiving Victoza in combination with an insulin secretagogue (eg, sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia
Per the FDA, compounded drugs that contain DSIP may pose a risk for immunogenicity,26 a state in which the body perceives a substance as a threat and so mounts a potentially life-threatening immune response against it
The result is a condition called erythrocytosis, where the blood becomes thicker and more viscous than ideal
(PubMed) Karanikas G, Schuetz M, Kontur S, et al
Robert Popovian So the University of Minnesota is not only the largest hospital beneficiary, but it also has ties with one of the most significant contract pharmacy arrangements in the state of Minnesota